Monthly Archives: November 2025

The Department of Health and Social Care (DHSC) has announced that from the start of 2026, the Ministry of Defence (MOD) will start using paper FP10 prescription forms for all outsourced prescriptions issued by MOD medical facilities. Any MOD-issued paper FP10 prescriptions should be processed by pharmacy teams in the usual way. The small number of MOD-issued [...]

The post Ministry of Defence (MOD) using paper FP10 prescriptions appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (21/11/2025) confirmed the following list of price concessions for November 2025: Drug Pack size Price concession Amiodarone 100mg tablets 28 £4.30 Bumetanide 1mg tablets 28 £2.56 Clotrimazole 500mg pessaries 1 £5.34 Co-codamol 30mg/500mg tablets 30 £1.35 Co-codamol 30mg/500mg tablets 100 £4.49 Fluticasone 400microgram/unit dose nasal drops 30 [...]

The post November 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has announced that the NHS prescription charge will remain at £9.90 per prescription item for 2026/27. A Government press release today confirms that the NHS prescription charge will be frozen, as well as the costs for prescription prepayment certificates (PPCs). The list of 2026/27 prescription-related charges are outlined below. [...]

The post NHS prescription charges frozen for the second year running appeared first on Community Pharmacy England.

Politicians and policy experts have cited integration, localism and prevention as some of the core components required to build a future-fit NHS. The themes have been identified in a written report on Community Pharmacy England’s series of policy events at this year’s political party conferences. The discussions concluded that community pharmacy, in particular, is foundational [...]

The post Integration, localism and prevention key to building a future-fit NHS appeared first on Community Pharmacy England.

Underinvestment in the sector is continuing to threaten the accessibility of community pharmacies to patients and the public, Community Pharmacy England has told a Parliamentary inquiry. Dr. James Davies, Director of Research and Insights at Community Pharmacy England, gave oral evidence to the All-Party Parliamentary Health Group (APHG) on Wednesday 19th November. The APHG’s inquiry [...]

The post Underinvestment threatening patient access to pharmacy, Health APPG hears appeared first on Community Pharmacy England.